POSSIBLE OBSTACLES AND PITFALLS DURING BIOPHARMACEUTICAL PROCESSING OF HIGH CONCENTRATION LIQUID FORMULATIONS (HCLF)

机译：高浓度液体制剂（HCLF）生物制药过程中的可能障碍物

获取原文

页面导航

著录项
相似文献
相关主题

著录项

来源
《Conference on biological and pharmaceutical complex fluids》|2019年|22-22|共1页
会议地点 Hernstein(AT)
作者
Daniel Molnar;
展开▼
作者单位

Boehringer Inqelheim Pharma GmbH Co. KG;

展开▼
会议组织
原文格式 PDF
正文语种
中图分类
关键词
high concentration liquid formulation; biopharmaceutical processing; fill and finish;

机译：高浓度液体制剂;生物制药加工;填充并完成;

相似文献

外文文献
中文文献
专利

1. Progress in the Development of Aqueous Two-Phase Systems Comprising Ionic Liquids for the Downstream Processing of Protein-Based Biopharmaceuticals [J] . Leonor S. Castro, Patricia Pereira, Mara G. Freire, American pharmaceutical review . 2019,第6期

机译：一种在蛋白质的生物制药下游加工的离子液体的开发过程中的进展
2. Development of high concentration protein biopharmaceuticals: the use of platform approaches in formulation development. [J] . Warne NW European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V . 2011,第2期

机译：高浓度蛋白质生物药物的开发：在制剂开发中使用平台方法。
3. Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation [J] . Bernd Liedert, Ulf Forssmann, Peter Wolna, BMC Pharmacology and Toxicology . 2010,第1期

机译：比较两种浓度的新型液体重组人生长激素制剂与冻干制剂的药代动力学，安全性和耐受性
4. POSSIBLE OBSTACLES AND PITFALLS DURING BIOPHARMACEUTICAL PROCESSING OF HIGH CONCENTRATION LIQUID FORMULATIONS (HCLF) [C] . Daniel Molnar Conference on biological and pharmaceutical complex fluids . 2019

机译：高浓度液体制剂的生物制药过程中可能的障碍和缺陷（HCLF）
5. In silico formulation: Application of artificial intelligence in support of hard gelatin capsule formulation of biopharmaceutics classification system class II drugs. [D] . Wilson, Wendy I. 2004

机译：在计算机制剂中：人工智能在支持硬明胶胶囊制剂中的生物药物分类系统II类药物的应用。
6. Comparison of the pharmacokinetics safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation [O] . Bernd Liedert, Ulf Forssmann, Peter Wolna, 2010

机译：比较两种浓度的新型液体重组人生长激素制剂与冻干制剂的药代动力学安全性和耐受性
7. Comparison of the pharmacokinetics, safety and tolerability of two concentrations of a new liquid recombinant human growth hormone formulation versus the freeze-dried formulation [O] . Bernd Liedert, Ulf Forssmann, Peter Wolna, 2010

机译：比较两种浓度的新型液体重组人生长激素制剂与冻干制剂的药代动力学，安全性和耐受性

POSSIBLE OBSTACLES AND PITFALLS DURING BIOPHARMACEUTICAL PROCESSING OF HIGH CONCENTRATION LIQUID FORMULATIONS (HCLF)

著录项

相似文献

相关主题

期刊订阅